Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSA-Free Varilrix Formulation Study
NCT00568334Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2007
- Primary completion
- Mar 2008
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 2
01
Overview
A Phase 2 trial of varicella virus vaccine live in varicella (VZV), sponsored by GSK. Started Nov 2007; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT00568334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568334.